SCHEMBL9854331

SCHEMBL9854331

N#Cc1ccccc1-c1ccc(CNc2ncccc2N)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 7/20 0.52
CYP3A4 P08684 7/20 0.52
ALDH1A1 P00352 5/20 0.52
HSD17B10 Q99714 5/20 0.52
CYP2C19 P33261 5/20 0.52
CYP2C9 P11712 5/20 0.52
TSHR P16473 5/20 0.52
CLK4 Q9HAZ1 3/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
CYP2D6 P10635 2/20 0.52
USP2 O75604 2/20 0.52
MAPK1 P28482 1/20 0.52
BLM P54132 1/20 0.52
HPGD P15428 5/20 0.48
THRB P10828 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
BDKRB1 P46663 7/20 0.46
KDM4E B2RXH2 2/20 0.44
TP53 P04637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27407042 0.86 WNT3A (0.46) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
SCHEMBL6759307 0.78 BDKRB1 (0.42) BDKRB1BACE1HDAC1
SCHEMBL31631318 0.77 BACE1 (0.65) ALDH1A1TSHRMEN1KMT2AMAPK1
SCHEMBL6285864 0.77 BACE1 (0.65) ALDH1A1TSHRMEN1KMT2AMAPK1
SCHEMBL16879487 0.77 HPGD (0.40) CYP1A2CYP3A4ALDH1A1CYP2C19CYP2C9
SCHEMBL3288539 0.76 HPGD (0.58) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
SCHEMBL6702252 0.75 HPGD (0.51) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
SCHEMBL20183521 0.74 HSD17B10 (0.53) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19
SCHEMBL6754038 0.74 BDKRB1 (0.70) BDKRB1
SCHEMBL30612292 0.74 HPGD (0.41) CYP1A2CYP3A4ALDH1A1HSD17B10CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0426021-A1 Condensed imidazole derivatives and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-05-08 EP disclosed